Cargando…

Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis

BACKGROUND: We previously showed that angiotensin type 1 receptor (AT1) blocker (ARB) attenuates glomerular injury in Nphs1-hCD25 (NEP25) transgenic mice, a model of selective podocyte injury. However, subsequent studies in NEP25 mice with podocyte-specific deficiency of AT1 revealed that the protec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Nobuaki, Tanizawa, Takakuni, Kon, Valentina, Fogo, Agnes B., Ichikawa, Iekuni, Ma, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318935/ https://www.ncbi.nlm.nih.gov/pubmed/22479265 http://dx.doi.org/10.1159/000334961

Ejemplares similares

Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker
por: Zhu, Xuejing, et al.
Publicado: (2022)

Maturational Regression of Glomeruli Determines the Nephron Population in Normal Mice
por: Zhong, Jianyong, et al.
Publicado: (2012)

Role of Podocyte Injury in Glomerulosclerosis
por: Lu, Chen-Chen, et al.
Publicado: (2019)

Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis
por: Kim, Jae Seok, et al.
Publicado: (2016)

Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016)

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
por: Dai, Rufeng, et al.
Publicado: (2019)

A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis
por: Tao, Jianling, et al.
Publicado: (2013)

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
por: Tezuka, Yuta, et al.
Publicado: (2022)

A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis
por: Iguchi, Akira, et al.
Publicado: (2013)

Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis
por: Taneda, Sekiko, et al.
Publicado: (2015)

Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
por: Angeletti, Andrea, et al.
Publicado: (2020)

Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis
por: Chhuon, Cerina, et al.
Publicado: (2023)

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
por: Li, Yuting, et al.
Publicado: (2023)

Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition
por: Dan Hu, Qiong‐, et al.
Publicado: (2023)

Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis—a review
por: Löwik, M. M., et al.
Publicado: (2009)

In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease
por: da Silva, Crislaine Aparecida, et al.
Publicado: (2020)

Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis
por: Tanoue, Akiko, et al.
Publicado: (2021)

Global transcriptomic changes in glomerular endothelial cells in mice with podocyte depletion and glomerulosclerosis
por: Fu, Jia, et al.
Publicado: (2021)

An Essential Role of the Universal Polarity Protein, aPKCλ, on the Maintenance of Podocyte Slit Diaphragms
por: Hirose, Tomonori, et al.
Publicado: (2009)

A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury
por: Solanki, Ashish K., et al.
Publicado: (2018)

Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
por: Bansal, S. B., et al.
Publicado: (2017)

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension
por: Narayan, Hafid, et al.
Publicado: (2016)

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
por: Rakugi, Hiromi, et al.
Publicado: (2020)

Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis
por: Eng, Diana G., et al.
Publicado: (2015)

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
por: Otalora, Lilian, et al.
Publicado: (2019)

Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice
por: Veron, Delma, et al.
Publicado: (2022)

Loss of phosphatidylserine flippase β-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis
por: Liu, Wenjing, et al.
Publicado: (2021)

Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes
por: Gazzard, Sarah E., et al.
Publicado: (2023)

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury
por: Luther, James M., et al.
Publicado: (2012)

Gα12 Activation in Podocytes Leads to Cumulative Changes in Glomerular Collagen Expression, Proteinuria and Glomerulosclerosis
por: Boucher, Ilene, et al.
Publicado: (2012)

Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis
por: Xiao, Bin, et al.
Publicado: (2018)

Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
por: Zhuang, Qiyuan, et al.
Publicado: (2020)

Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment
por: Wang, Juan, et al.
Publicado: (2018)

FAM40A alters the cytoskeleton of podocytes in familial focal and segmental glomerulosclerosis by regulating F-actin and nephrin
por: Chen, Zhou, et al.
Publicado: (2018)

Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure
por: Iwata, Wakiko, et al.
Publicado: (2020)

Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis
por: van de Lest, Nina A., et al.
Publicado: (2021)

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes
por: den Braanker, Dirk J. W., et al.
Publicado: (2022)

Podocyte ACE2 protects against diabetic nephropathy
por: Harris, Raymond C.
Publicado: (2012)

Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats
por: Rahman, Asadur, et al.
Publicado: (2021)

Characterization of Direct Perturbations on Voltage-Gated Sodium Current by Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker
por: Chang, Wei-Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r5c3p4kefdh4kgh7m4m4f2ub79